MUCOTEC 150MG 20TAB; erdosteine, respiratory tract agents .
ACTIVE-INGREDIENT OF MUCOTEC 150MG 20TAB
Each Mucotec Capsule contains: 150 mg erdosteine.
INDICATION OF MUCOTEC 150MG 20TAB
1- Treatment of patients with acute or chronic bronchopulmonary diseases (such as bronchitis, rhinitis, sinusitis, laryngopharyngitis, & exacerbation of chronic diseases), associated with mucous production & transport. 2- Preventive treatment of stable chronic bronchitis in smoking subjects, in recurrent episodes during winter season & related conditions. 3- Co-treatment with antibiotics in case of exacerbation with bacterial infections.
DOSAGE OF MUCOTEC 150MG 20TAB
Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet
Ask your pharmacist or doctor for help if you do not understand the instructions on the box .
The recommended dose is : –
Two capsules of 150 mg to be taken twice daily.
OVER-DOSAGE OF MUCOTEC 150MG 20TAB
CONTRA-INDICATION OF MUCOTEC 150MG 20TAB
Known hypersensitivity reactions of erdosteine. Severe hepatic & renal insufficiency.
STORAGE OF MUCOTEC 150MG 20TAB
Store at a room temperature away from humidity.
PACK OF MUCOTEC 150MG 20TAB
Capsules are supplied in boxes of 20 capsules each.
MUCOTEC 150MG 20TAB MANUFACTURED BY
GLOBAL NAPI PHARMACEUTICALS 2nd Industrial Zone, 6 October City – Egypt www.globalnapi.com Under licence from: Stada – Germany For Germa Pharma Ltd.